The purpose of this study is to determine the safety and efficacy of Injectrode Tibial Nerve Stimulation for bladder function in people with spinal cord injury.
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Safety as assessed by the number of device-related adverse events
Timeframe: From baseline to 8 weeks
Accuracy as assessed by the percentage of sessions where toe flexion was achieved as recorded in subject logs.
Timeframe: From baseline to week 8
Reliability as assessed by the average minimum current (mA) required to elicit toe flexion when testing for accuracy
Timeframe: From baseline to week 8
Feasibility of Injectrode procedure as assessed by surveys
Timeframe: Week 8
Physician acceptability of Injectrode device as assessed by a survey
Timeframe: Week 8
Participant acceptability of Injectrode device as assessed by a survey
Timeframe: Week 8
Feasibility and acceptability of the Injectrode treatment as assessed by a qualitative interview
Timeframe: Week 8